| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/28/2006 | CN1261130C Medicine for dispelling tinea |
| 06/28/2006 | CN1261126C Medicine for treating bone and joint tuberculosis |
| 06/28/2006 | CN1261110C Medicinal composition for treating common and infectious cold |
| 06/28/2006 | CN1261101C Chitosan glycyrrhizie acid nano particle and its preparing method |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/28/2006 | CN1261096C Compound preparation of reveratrol and application |
| 06/28/2006 | CN1261092C New use of glutaraldehyde in preparing animal medicine |
| 06/27/2006 | USRE39151 Process for the preparation and purification of thiol-containing maytansinoids |
| 06/27/2006 | USRE39149 Method of administering azithromycin |
| 06/27/2006 | US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals |
| 06/27/2006 | US7067681 Nitration of tetracyclines and derivatives, then reducing, diazotizing and alkylation on the presence of palladium chloride; catalysis; antibiotics |
| 06/27/2006 | US7067624 Antimicrobial proteins |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067511 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067493 Single dose azithromycin |
| 06/27/2006 | US7067487 Amino acid sequence having homology with amino acid position 194 to 220 in a pestiviral Erns protein RNase, from 59-88 in a L3 loop of a cytotoxic RNase of a ribosome-inactivating protein, or 187- 223 in respiratory syncytial virus |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067483 Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin |
| 06/27/2006 | US7067482 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/27/2006 | US7067481 Glycopeptide group is covalently linked to a pyridinium moiety of a cephalosporin group; reacting a glycopeptide containing (c6.c6.c6.c6.c6.c10n2.c13n2o.c13n2o ring) with a cephalosporin or salt in presence of a diacid |
| 06/27/2006 | US7067310 Generation plasmid in prokaryotic cell; obtain cell, incubate with nucleotide sequences, transform cell, allow homologouus recombination to occur, recover recombinamt plasmid |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067248 Screening method for orthopoxvirus antivirals |
| 06/27/2006 | US7067247 Comprises mutant hepatitis B surface antigen for detecting viral diseases; immunoassays; kidney disorders |
| 06/27/2006 | US7067135 RAP (RNAIII activating protein) polypeptide of amino acid sequence 13 |
| 06/27/2006 | US7067114 Delivery of antihistamines through an inhalation route |
| 06/27/2006 | US7067112 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline |
| 06/27/2006 | US7066184 use of selected uncharged and cationic benzotriazole UV absorbers in the cosmetic treatment of human hair for protection against UV radiation; have affinity for hair so stays for longer periods |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/27/2006 | CA2195935C Streptococcus equi vaccine |
| 06/24/2006 | CA2529265A1 Quinoline derivatives for the treatment of latent tuberculosis |
| 06/22/2006 | WO2006065590A2 Pyridine and pyrimidine antiviral compositions |
| 06/22/2006 | WO2006065166A1 Protein l1 and protein e7 peptide-based composition for treating and preventing a human papillomaviral infection |
| 06/22/2006 | WO2006064914A1 Neuraminidase inhibitor |
| 06/22/2006 | WO2006064790A1 Apoptosis inducer for cancer cells, metastasis inhibitor for cancer cells, anticancer agent, food product, anti-hiv agent and food product having anti-hiv effect |
| 06/22/2006 | WO2006064376A1 Peptides for treating retrovirus infection |
| 06/22/2006 | WO2006064277A1 Silicon compounds and their use |
| 06/22/2006 | WO2006064263A1 Silicon compounds and their use |
| 06/22/2006 | WO2006064026A1 Treatment of hepatitis c in the asian population with interferon-beta |
| 06/22/2006 | WO2006063801A1 Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl)carbamic acid 2-(s)-hydroxymutilin 14-ester |
| 06/22/2006 | WO2006063523A1 A polyvalent attenuated live vaccine for preventing and curing vibriosis of cultivated fish |
| 06/22/2006 | WO2006063518A1 Multifunctional polypeptides |
| 06/22/2006 | WO2006063445A1 Recombinant foot and mouth disease vaccine |
| 06/22/2006 | WO2006063425A1 Expression vectors for treating bacterial infections |
| 06/22/2006 | WO2006063402A1 Therapeutic compositions based on extracts of plants from the genus plumeria (frangipani) |
| 06/22/2006 | WO2006032525B1 Combinational therapy for treating cancer |
| 06/22/2006 | WO2006032500A3 Immunogenic composition |
| 06/22/2006 | WO2006024741A3 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | WO2005084671A3 Combination of voriconazole and an antifungal cyp2c19 inhibitor |
| 06/22/2006 | WO2005025487A9 Oligonucleotides targeting prion diseases |
| 06/22/2006 | WO2005020884A3 Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135589 1h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors |
| 06/22/2006 | US20060135573 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 06/22/2006 | US20060135568 Methods of treating microbial infections in humans and animals |
| 06/22/2006 | US20060135566 E.g., N-[5-(2-Benzoylamino-4-pyridyl)-4-(3,5-dimethylphenyl)-1,3-thiazol-2-yl]acetamide,; the compounds have adenosine A3 receptor antagonistic activity, a p38 MAP kinase inhibitory action, and a TNF- alpha production-inhibitory action |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135516 3-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135458 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses |
| 06/22/2006 | US20060135456 Methods and compositions for RNA interference |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060135451 Vaccine |
| 06/22/2006 | US20060134764 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 06/22/2006 | US20060134286 Gallocatechin gallate-containing composition |
| 06/22/2006 | US20060134208 Controlled release and taste masking oral pharmaceutical composition |
| 06/22/2006 | US20060134205 Process for preparing a pharmaceutical composition |
| 06/22/2006 | US20060134186 Oxygenating agents for enhancing host responses to microbial infections |
| 06/22/2006 | US20060134143 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
| 06/22/2006 | US20060134101 Use of avian antibodies |
| 06/22/2006 | US20060134100 Dc-sign blockers and their use for preventing or treating viral infections |
| 06/22/2006 | US20060134065 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 06/22/2006 | US20060134011 Oral and dental composition |
| 06/22/2006 | DE19801821B4 Tuberkulozides Desinfektionsmittel Tuberculocidal disinfectant |
| 06/22/2006 | CA2592366A1 Recombinant foot and mouth disease vaccine |
| 06/22/2006 | CA2592344A1 Expression vectors for treating bacterial infections |
| 06/22/2006 | CA2590881A1 Silicon compounds and their use |
| 06/22/2006 | CA2590877A1 Silicon compounds and their use |
| 06/22/2006 | CA2589498A1 Treatment of hepatitis c in the asian population with interferon-beta |
| 06/22/2006 | CA2587285A1 Actinomadura chromoprotein, apoprotein, and gene cluster |
| 06/21/2006 | EP1672065A1 Protein expressed in nk cell |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671644A2 Pharmaceutical compositions containing Lysostaphin alone or in combination with an antibiiotic for the treatment of Staphylococcal infections |
| 06/21/2006 | EP1671643A1 Medicinal composition for treating chronic hepatitis c |
| 06/21/2006 | EP1671639A1 Treatment of acquired immunedeficiency syndrome AIDS with a combination therapy including curdlan sulphate |
| 06/21/2006 | EP1671635A1 Noncrystalline antibacterial composition containing cefditoren pivoxil |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1671629A1 Human beta-defensin secretion promoter |
| 06/21/2006 | EP1671625A1 Nanoparticles |